Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study.
Chardin D, Paquet M, Schiappa R, Darcourt J, Bailleux C, Poudenx M, Sciazza A, Ilie M, Benzaquen J, Martin N, Otto J, Humbert O. Chardin D, et al. Among authors: martin n. J Immunother Cancer. 2020 Jul;8(2):e000645. doi: 10.1136/jitc-2020-000645. J Immunother Cancer. 2020. PMID: 32709713 Free PMC article.
Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Saleh K, Daste A, Martin N, Pons-Tostivint E, Auperin A, Herrera-Gomez RG, Baste-Rotllan N, Bidault F, Guigay J, Le Tourneau C, Saada-Bouzid E, Even C. Saleh K, et al. Among authors: martin n. Eur J Cancer. 2019 Nov;121:123-129. doi: 10.1016/j.ejca.2019.08.026. Epub 2019 Sep 28. Eur J Cancer. 2019. PMID: 31574417
Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer.
Humbert O, Bauckneht M, Gal J, Paquet M, Chardin D, Rener D, Schiazza A, Genova C, Schiappa R, Zullo L, Rossi G, Martin N, Hugonnet F, Darcourt J, Morbelli S, Otto J. Humbert O, et al. Among authors: martin n. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3878-3891. doi: 10.1007/s00259-022-05788-8. Epub 2022 May 14. Eur J Nucl Med Mol Imaging. 2022. PMID: 35562529 Free PMC article.
Safety and efficacy of two-drug combination in elderly patients with locally advanced non-small cell lung cancer and validation of the Charlson Index as a predictor of survival.
Lach M, Otto J, Bondiau PY, Boulahssass R, Schiappa R, Jazmati D, von Krüchten R, Martin N, Doyen J. Lach M, et al. Among authors: martin n. J Thorac Dis. 2023 Jul 31;15(7):3764-3775. doi: 10.21037/jtd-23-108. Epub 2023 Jul 3. J Thorac Dis. 2023. PMID: 37559621 Free PMC article.
[18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal.
Masse M, Chardin D, Tricarico P, Ferrari V, Martin N, Otto J, Darcourt J, Comte V, Humbert O. Masse M, et al. Among authors: martin n. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3696-3708. doi: 10.1007/s00259-024-06794-8. Epub 2024 Jun 19. Eur J Nucl Med Mol Imaging. 2024. PMID: 38896129 Free PMC article.
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study.
Oza AM, Selle F, Davidenko I, Korach J, Mendiola C, Pautier P, Chmielowska E, Bamias A, DeCensi A, Zvirbule Z, González-Martín A, Hegg R, Joly F, Zamagni C, Gadducci A, Martin N, Robb S, Colombo N. Oza AM, et al. Among authors: martin n. Int J Gynecol Cancer. 2017 Jan;27(1):50-58. doi: 10.1097/IGC.0000000000000836. Int J Gynecol Cancer. 2017. PMID: 27749456 Free PMC article. Clinical Trial.
High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma.
Martin N, Borchiellini D, Coso D, Gastaud L, Boscagli A, Saudes L, Re D, Gutnecht J, Garnier G, Petit E, Barriere J, Naman H, Rossignol B, Thyss A, Peyrade F. Martin N, et al. Leuk Lymphoma. 2015;56(8):2379-87. doi: 10.3109/10428194.2014.1001987. Epub 2015 Feb 20. Leuk Lymphoma. 2015. PMID: 25563428
Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial.
González-Martín A, Pautier P, Mahner S, Rau J, Colombo N, Ottevanger P, Del Campo JM, Selle F, du Bois A, Gadducci A, García Y, Berton-Rigaud D, Marmé F, Ortega E, Martin N, Bastiere-Truchot L, Kiermaier A, Kurzeder C. González-Martín A, et al. Among authors: martin n. Int J Gynecol Cancer. 2016 Jun;26(5):898-905. doi: 10.1097/IGC.0000000000000695. Int J Gynecol Cancer. 2016. PMID: 27206218 Clinical Trial.
5,404 results